SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-015566
Filing Date
2019-08-06
Accepted
2019-08-06 10:27:17
Documents
76
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20190630b_10q.htm 10-Q 1299815
2 EXHIBIT 10.1 ex_151471.htm EX-10.1 58430
3 EXHIBIT 10.3 ex_151472.htm EX-10.3 20386
4 EXHIBIT 31.1 ex_148172.htm EX-31.1 14856
5 EXHIBIT 31.2 ex_148173.htm EX-31.2 14837
6 EXHIBIT 32 ex_148174.htm EX-32 5989
  Complete submission text file 0001437749-19-015566.txt   5534115

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT oxfd-20190630.xml EX-101.INS 1049831
8 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20190630.xsd EX-101.SCH 53495
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxfd-20190630_cal.xml EX-101.CAL 66106
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxfd-20190630_def.xml EX-101.DEF 375746
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20190630_lab.xml EX-101.LAB 309252
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20190630_pre.xml EX-101.PRE 401787
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 191000790
SIC: 2835 In Vitro & In Vivo Diagnostic Substances